Attitudes and beliefs about Vermont's 2021 buprenorphine decriminalization law among residents who use illicit opioids

Kenneth A. Feder, Samantha J. Harris, Lauren Byrne, Samantha M. Miller, Shereen Sodder, Vanessa Berman, Amy Livingston, Jessica Edwards, Shane Hartman, Olivia K. Sugarman, Hridika Shah, Justin Xu, Jewyl Raikes, Sabrina Gattine, Brendan Saloner

Research output: Contribution to journalArticlepeer-review

Abstract

Background: In July 2021, Vermont removed all criminal penalties for possessing 224 mg or less of buprenorphine. Methods: Vermont residents (N=474) who used illicit opioid drugs or received treatment for opioid use disorder in the past 90 days were recruited for a mixed-methods survey on the health and criminal legal effects of decriminalization. Topics assessed included: motivations for using non-prescribed buprenorphine, awareness of and support for decriminalization, and criminal legal system experiences involving buprenorphine. We examined the frequencies of quantitative measures and qualitatively summarized themes from free-response questions. Results: Three-quarters of respondents (76%) reported lifetime use of non-prescribed buprenorphine. 80% supported decriminalization, but only 28% were aware buprenorphine was decriminalized in Vermont. Respondents described using non-prescribed buprenorphine to alleviate withdrawal symptoms and avoid use of other illicit drugs. 18% had been arrested while in buprenorphine, with non-White respondents significantly more likely to report such arrests (15% v 33%, p<0.001). Conclusion: Decriminalization of buprenorphine may reduce unnecessary criminal legal system involvement, but its health impact was limited by low awareness at the time of our study.

Original languageEnglish (US)
Article number110879
JournalDrug and alcohol dependence
Volume250
DOIs
StatePublished - Sep 1 2023

Keywords

  • Buprenorphine
  • Decriminalization
  • Opioids
  • State policy, mixed methods

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Toxicology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Attitudes and beliefs about Vermont's 2021 buprenorphine decriminalization law among residents who use illicit opioids'. Together they form a unique fingerprint.

Cite this